Latest News

Blood Cancer Drugs Overpriced
Patients face significant financial burdens from treatment.
CEO of Avella Specialty Pharmacy Rebecca M. Shanahan, Esq., discusses how specialty pharmacies can best manage the rising cost of specialty drugs to improve outcomes for patients.
Specialty and community pharmacies more involved in cancer treatment.
Drug targets the cause of the disease in people who have two copies of a specific mutation.
Coverage restrictions on wrong side of Medicaid law requiring states to cover drugs consistent with FDA labels.
Ocrelizumab may shift MS treatment paradigm.
Study finds current efforts are not enough to decrease the spread of infection.
There are currently more than 600 trials of biosimilars ongoing.

Features

Recently published data from a survey of commercial health plans reveal the latest trends and emerging strategies in oncology management.
Anticipated near-term specialty drug approvals include new therapies for cancer, orphan conditions, high cholesterol, and asthma.
Mobile adherence apps are a great boon to patients who face the responsibility of taking oral chemotherapy drugs as directed without in-person supervision by clinicians.
Pharmaceutical companies and clinical oncology teams are collaborating to harness large sets of patient data, paving the way for more informed and individualized decision-making about treatments.
As oncology spending rises, insurers and manufacturers are looking to specialty pharmacy programs to maximize the effectiveness of cancer therapies.
There are several key factors a specialty pharmacy must consider when deciding whether to participate in a limited distribution network.

Videos

CEO of Avella Specialty Pharmacy Rebecca M. Shanahan, Esq., discusses how specialty pharmacies can best manage the rising cost of specialty drugs to improve outcomes for patients.

Michael Zeglinski, Vice President of Specialty Pharmacy Operations at BriovaRx, discusses developing trends in the treatment of specialty pharmacy patients.

Amy Grogg, PharmD, senior vice president of Strategy and Commercialization at AmerisourceBergen Specialty Group discusses how the Affordable Care Act has emphasized the importance of specialty pharmacy services.

Ron Lanton III, Esq, president of True North Political Solutions, LLC, discusses how the specialty pharmacy landscape will evolve in the coming years.

SPT Industry Guide

Current Issue

May/June 2015
Volume: 6
Number: 3

Featured Company Profile

HIV Pharmacists: Critical Partners on the HIV Care Team
The American Academy of HIV Medicine has certified thousands of providers with specialist or expert designations.
Company Profile >
Contributor >
Industry Guide >
Market News >
Peer Exchange >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Tech-Specs
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
HCPLive
ONCLive
Targeted Oncology
Physicians' Education Resource
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2015
Intellisphere, LLC. All Rights Reserved.

$vacMongoViewPlus$